ライフサイエンスコーパス: apnea syndrome

1 cs with moderate to severe obstructive sleep apnea syndrome.

2 , 697 (68 percent) had the obstructive sleep apnea syndrome.

3 sleep in patients with the obstructive sleep apnea syndrome.

4 ant in the pathogenesis of obstructive sleep apnea syndrome.

5 diovascular abnormality in obstructive sleep apnea syndrome.

6 usion which results in the obstructive sleep apnea syndrome.

7 tested as pharmacologic treatments for sleep apnea syndrome.

8 io of %EFV to %VAF loss decreased with sleep apnea syndrome (1.34+/-0.3 vs. 0.52+/-0.08, p<0.05).

9 regarding the evolution of obstructive sleep apnea syndrome and persistence of abnormal pharyngeal se

10 rders of ventilatory control including sleep apnea syndromes and obesity hypoventilation syndrome.

11 tive apneas in patients with the obstructive apnea syndrome are accompanied by transient limb vasocon

12 uded obesity hypoventilation syndrome, sleep apnea syndrome, hypertension, gastroesophageal reflux, d

13 nt condition for the production of the sleep apnea syndrome in normal individuals.

14 significant prevalence of obstructive sleep apnea syndrome in patients in waiting list for LT, and L

15 surgical treatment for the obstructive sleep apnea syndrome in school-age children did not significan

16 ne patients with untreated obstructive sleep apnea syndrome in wakefulness and sleep.

17 Obstructive sleep apnea syndrome involves abnormal upper airway sensory in

18 Obstructive sleep apnea syndrome is a highly prevalent disease resulting i

19 Obstructive sleep apnea syndrome is a well recognized cause of excessive s

20 firm previous reports that obstructive sleep apnea syndrome is associated with reduced parasympatheti

21 Sleep apnea syndrome is one of a series of sleep-related breat

22 reathing, particularly the obstructive sleep apnea syndrome, is common during childhood.

23 es have suggested that the obstructive sleep apnea syndrome may be an important risk factor for strok

24 f these findings for the management of sleep apnea syndrome must be verified by appropriate clinical

25 independent effect of the obstructive sleep apnea syndrome on the composite outcome of stroke or dea

26 ody mass index [BMI] >35), obstructive sleep apnea syndrome, or other causes of respiratory failure.

27 Many patients with obstructive sleep apnea syndrome (OSA) living near sea level travel to alt

28 23%) than in subjects with obstructive sleep apnea syndrome (OSAS) (0.06%), parasomnia (0.7%), restle

29 s modestly associated with obstructive sleep apnea syndrome (OSAS) among young children, but strongly

30 Obstructive sleep apnea syndrome (OSAS) and nonalcoholic fatty liver disea

31 hypoxia (CIH) occurs with obstructive sleep apnea syndrome (OSAS) and provokes systemic endothelial

32 treatment in children with obstructive sleep apnea syndrome (OSAS) associated with significant hypoxe

33 Children with obstructive sleep apnea syndrome (OSAS) have more collapsible airways comp

34 er airway in children with obstructive sleep apnea syndrome (OSAS) have not been established.

35 The prevalence of obstructive sleep apnea syndrome (OSAS) in patients with nonarteritic ante

36 The obstructive sleep apnea syndrome (OSAS) is associated with cardiovascular

37 Obstructive sleep apnea syndrome (OSAS) is associated with intermittent hy

38 thophysiology of pediatric obstructive sleep apnea syndrome (OSAS) is suggested by the observation th

39 Obstructive sleep apnea syndrome (OSAS) is usually diagnosed with overnigh

40 Obstructive sleep apnea syndrome (OSAS) leads to neurocognitive and autono

41 tudies suggesting that the obstructive sleep apnea syndrome (OSAS) may compromise optic nerve head pe

42 te the correlation between obstructive sleep apnea syndrome (OSAS) risk with periodontal disease and

43 patients with concomitant obstructive sleep apnea syndrome (OSAS) seems to have a favorable impact o

44 Obstructive sleep apnea syndrome (OSAS), a disorder characterized by episo

45 reported in patients with obstructive sleep apnea syndrome (OSAS), and these two chronic conditions

46 le in treating snoring and obstructive sleep apnea syndrome (OSAS).

47 s-dependent cognition, and obstructive sleep apnea syndrome (OSAS).

48 cally in children with the obstructive sleep apnea syndrome (OSAS).

49 essure (CPAP) titration in obstructive sleep apnea syndrome (OSAS).

50 athing in 10 children with obstructive sleep apnea syndrome (OSAS; age, 4.3 +/- 2.3 years) and 10 mat

51 allampati score III or IV, obstructive sleep apnea syndrome, reduced mobility of cervical spine, limi

52 ion, and hypertension, the obstructive sleep apnea syndrome retained a statistically significant asso

53 ome (FES) and body mass index (BMI) in sleep apnea syndrome (SAS) patients compared to normal subject

54 isease, morbid obesity associated with sleep apnea syndrome, sickle cell disease, and polycythemic st

55 The obstructive sleep apnea syndrome significantly increases the risk of strok

56 o 9 years of age, with the obstructive sleep apnea syndrome to early adenotonsillectomy or a strategy

57 Prevalence of obstructive sleep apnea syndrome was 38% before the LT, 86% at 6 months, a

58 n unadjusted analysis, the obstructive sleep apnea syndrome was associated with stroke or death from

59 The diagnosis of the obstructive sleep apnea syndrome was based on an apnea-hypopnea index of 5

60 that, in children with the obstructive sleep apnea syndrome without prolonged oxyhemoglobin desaturat

61 ormed in children with the obstructive sleep apnea syndrome, yet its usefulness in reducing symptoms